Impact of surgical adjuvant chemotherapy on quality of life(QOL) of patients with breast cancer(BC) for the second year of treatment-A phase III randomized trial comparing UFT(Uracil/Tegafur) with CMF in high-risk node-negative patients(NSAS-BC 01)
収録刊行物
-
- ASCO Proc
-
ASCO Proc 20 401a-, 2001